However, overexpression of EIF4B and its phospho-mimicking variants (S406D, S422D) in the KEP tumor–derived cell line KEP2.E3 (Klarenbeek et al., 2020) did not confer resistance to AZD8055 in vitro (Fig. S1, E and F). Here, EIF4B is linked to neoplasm.